Security key
34960Q307
- Security type / class
- Equity / COM NEW
- Total 13F shares
- 4,960,694
- Total 13F value
- $9,226,455
- Share change
- +48,353
- Put/Call ratio
- 132%
- SEC-reported price per share
- $1.86
- Number of holders
- 49
- Value change
- +$452,125
- Number of buys
- 26
- Number of sells
- 20
Open additional details 1 more signal available
Report period
Q2 2025
Institutions
49
Top holders
10
FBIO full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Fortress Biotech, Inc. SEC filings
Fortress Biotech, Inc. company facts
Fortress Biotech, Inc. 13D/G history
Broader feeds
Reporting periods
Holder history for CUSIP 34960Q307
Recent filing periods:
Ownership snapshot
Top reported holders of FBIO - Fortress Biotech, Inc. - COM NEW (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Cambridge Investment Rese...
Disclosed value leader
Cambridge Investment Rese...
Comparable rows
0/15
Latest evidence
31 Mar 2025
13F
3/4/5
Highest disclosed value: $1,567,000
15 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Cambridge Investment Research Advisors, Inc. has the largest disclosed position value at $1.57M.
0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Cambridge Investment Research Advisors, Inc.'s linked filing trail.
Disclosed position value
Top 5
Cambridge Investment Research Adv...
$1.57M
VANGUARD GROUP INC
$1.17M
PVG ASSET MANAGEMENT CORP
$736.7K
Nantahala Capital Management, LLC
$507.8K
Kestra Advisory Services, LLC
$456.3K
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Cambridge Investment Research Advisors, Inc. |
13F
Company
|
—
class O/S missing
|
$1,567,000
1,004,365 shares
|
— | 31 Mar 2025 |
| VANGUARD GROUP INC |
13F
Company
|
—
class O/S missing
|
$1,173,979
752,551 shares
|
— | 31 Mar 2025 |
| PVG ASSET MANAGEMENT CORP |
13F
Company
|
—
class O/S missing
|
$736,665
472,221 shares
|
— | 31 Mar 2025 |
| Nantahala Capital Management, LLC |
13F
Company
|
—
class O/S missing
|
$507,811
325,520 shares
|
— | 31 Mar 2025 |
| Kestra Advisory Services, LLC |
13F
Company
|
—
class O/S missing
|
$456,270
292,481 shares
|
— | 31 Mar 2025 |
| ENVESTNET ASSET MANAGEMENT INC |
13F
Company
|
—
class O/S missing
|
$417,936
267,908 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
49
Shares
4,960,694
Rows available
49
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
46
Q2 2025 holders
49
Holder diff
3
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend